ArticleJournal of orthopaedic case reports2026
Antiphospholipid Syndrome-Associated Livedoid Vasculopathy Mimicking Recurrent Periprosthetic Joint Infection after Total Knee Arthroplasty: A Case Report.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) is a serious complication whose diagnosis relies on a combination of serum and synovial biomarkers. Inflammatory non-infectious conditions can fulfill these same diagnostic criteria, creating a diagnostic and therapeutic challenge. We report the first case, to our knowledge, of antiphospholipid syndrome (APS)-associated Livedoid vasculopathy (LV) mimicking recurrent PJI. Case Report: A 74-year-old White male with a remote history of uncomplicated right TKA presented with two discrete episodes of presumed PJI (November 2025 and January 2026), each coinciding with a new right ankle lesion. Synovial fluid analysis on both occasions demonstrated markedly elevated white blood cell counts (WBC) (20,688 and 28,900 cells/µL; >93% neutrophils) and a positive synovasure α-defensin, yielding a 2018 International Consensus Meeting score of 10 on each presentation. Cultures and next-generation sequencing (NGS) were uniformly negative. The ankle lesions were ultimately biopsied and confirmed histologically as LV. Serology subsequently established a double-positive APS profile (positive lupus anticoagulant and anti-β2-glycoprotein I antibodies). All antimicrobials were discontinued; the patient declined two-stage revision arthroplasty. Repeat aspiration 3 weeks later showed completely normal synovial fluid (WBC 28 cells/µL, synovial C-reactive protein 0.01 mg/L). At 12 weeks off all therapy, the patient remains asymptomatic. Conclusion: APS-associated LV can produce a thrombo-inflammatory sterile synovitis that satisfies established PJI diagnostic criteria, including a positive α-defensin. This case underscores the importance of evaluating concomitant dermatologic lesions, pursuing advanced microbiologic testing (NGS) before committing to surgical intervention, and considering hypercoagulable states in PJI workups with persistently negative cultures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.